Britain earmarks £50 million for NHS genetics

'Genetics offers prediction of risk, more precise diagnosis, more targeted and effective use of existing drugs, new gene-based drugs and therapies, and prevention and treatment regimes tailored to an individual's genetic profile.'

Photo: Britain earmarks £50 million for NHS genetics

A ‘Genetics Strategy for the NHS - ‘Our Inheritance, Our Future - Realising the Potential of Genetics in the NHS’, presented to Parliament in late June by John Reid, Secretary of State for Health, aims to set out a vision of how patients could benefit from future advances in genetics, and raise awareness of the potential of genetics in healthcare.

The ‘White Paper’ sets out a comprehensive plan to prepare the NHS, and includes an investment of £50 million over the next three years towards this initiative, by 
 Substantially upgrading genetics laboratories, and boosting the genetics workforce: more genetics counsellors, consultants and laboratory scientists
 Spending over £7 million on new initiatives to introduce genetics-based healthcare into the mainstream of the National Health Service
 Setting up a new Genetics Education and Development Centre to spearhead education and training in genetics for all healthcare staff
 Funding a new research programmes in pharmacogenetics, gene therapy and health services research to help turn the science into real patient benefit.

Safeguards and controls against inappropriate or unsafe use of genetics developments are also set out. In addition to existing controls on gene therapy and use of genetic test results by insurers, new legislation is planned, to ban DNA theft: it will become an offence to test someone’s DNA without their consent except for medical or police purposes.

The Government said it recognises the importance of openness and public debate, and will continue to respond to new developments and shifts in public attitudes


More on the subject:
Read all latest stories

Related articles


Cardiology research

Statins could reduce risk of cancer among heart failure patients

Statin use among patients with heart failure is associated with a 16% lower risk of developing cancer compared with non-statin users during an average of four years of follow-up. This is according to…


Unexpected find

Anti-tapeworm drug shows promise against Covid-19

Researchers from the German Center for Infection Research (DZIF) at Charité – Universitätsmedizin Berlin and the University of Bonn have examined the way in which SARS-CoV-2 reprograms the…



Stents can deliver drugs to the GI tract

Inspired by kirigami, the Japanese art of folding and cutting paper to create three-dimensional structures, MIT engineers and their collaborators have designed a new type of stent that could be used…

Subscribe to Newsletter